Funded Tech Companies
bluebird bio
Wondering who provided funding to bluebird bio? Shire Pharmaceuticals, Deerfield Capital and private investors invested in this biopharmaceutical company.
Company Overview
Company Name
bluebird bio
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
60 Binney St.
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Website
Email Address
Company Background Information
Overview
bluebird bio is developing innovative gene therapies for severe genetic disorders. Our vision is to make the hope of gene therapy a reality.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
6/19/2013
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nick Leschly
Chief Financial Officer
Jeffrey Walsh
Chief Medical Officer
David Davidson
Chief Scientific Officer
Philip Gregory
Chief Technical Officer
Derek Adams
VP - Bus. Development
Joanne Smith-Farrell
VP - General Counsel
Jason Cole
VP - Human Resources
Kathy Wilkinson
Company Investors
- Shire Pharmaceuticals
- Deerfield Capital (Howard Furst)
- RA Capital
- Third Rock Ventures (Robert Tepper)
- Forbion Capital Partners (Geert-Jan Mulder)
- Arch Venture Partners (Steven Gillis)
- Easton Capital
- TVM Capital (Axel Polack)
- Genzyme Ventures (James Geraghty)
- Third Rock Ventures (Nick Leschly)
- Forbion Capital Partners (Geert Mulder)
- Johnson & Johnson Development Corporation
- Nazem & Co.
- Easton Capital (John Friedman)
- TVM Capital (Stephen Hoffman)
Browse more funded tech companies:
Blueberry Protocol | Bluebirds
Share this article
About Our VC Deals Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs